Skip to main content

Selected Presentations by NCI Acting Director Dr. Douglas Lowy

NCI Principal Deputy Director Douglas Lowy speaks at a meeting of the National Cancer Advisory Board.

Credit: National Cancer Institute

Dr. Douglas R. Lowy delivers updates to NCI advisory boards and a variety of talks and briefings to the cancer community about strategic and scientific initiatives to advance cancer research and care.

NCI Advisory Board Presentations

A Perspective on the FY22 NCI Budget Appropriation
Board Of Scientific Advisors, March 28, 2022

NCI/DOE Collaboration
Frederick National Laboratory Advisory Committee, February 24, 2022

Allocation of NCI Appropriated Dollars for Research
Virtual National Cancer Advisory Board Meeting, September 1, 2021

NCI/DOE Collaboration — Implementation of NCI/DOE Collaboration Task Force Recommendations
Frederick National Laboratory Advisory Committee, June 28, 2021

NCI Serology Studies
NCI Council of Research Advocates, July 16, 2020

COVID-19 Research Initiatives at the Frederick National Laboratory
Virtual Meeting of the Frederick National Laboratory Advisory Committee, July 13, 2020

Update: COVID-19 Serology and Immunology Capacity Building
Virtual Meeting of the National Cancer Advisory Board and the Board of Scientific Advisors, June 15, 2020

Serology and Immunology Capacity Building
Virtual Meeting of the Frederick National Laboratory Advisory Committee, May 21, 2020

NCI Deputy Director's Report
Virtual Joint Meeting of NCI Board of Scientific Advisors & National Cancer Advisory Board, April 9, 2020

A Closer Look at the NCI Budget and RPG Pool
Joint Meeting of the National Cancer Advisory Board & Board of Scientific Advisors, December 3, 2019

NCI Director's Update
Frederick National Laboratory Advisory Committee, October 24, 2019

NCI Director's Update (slides, video)
National Cancer Advisory Board, September 4, 2019

NCI Director's Update
Clinical Trials and Translational Research Advisory Committee, July 17, 2019

NCI Director's Update
Frederick National Laboratory Advisory Committee, June 27, 2019

NCI Director's Update
RPG Pool Analysis
National Cancer Advisory Board & Board of Scientific Advisors, June 11, 2019

All Other NCI Presentations

Cancer Research Opportunities Funding and Progress
American Society of Clinical Oncology Annual Meeting, June 10, 2022

Equity in the Healthcare Workforce: Why it Matters for Patients
NCI Social Media Panel Discussion, June 9, 2022

Research Progress, Funding, and Opportunities: A Fireside Chat – Slides and audio only
American Association for Cancer Research Annual Meeting, April 11, 2022

The Molecular Basis of HPV–associated Cancers Underlies the HPV Vaccine and Today’s Cervical Cancer Screening 
American Society of Dermatopathology Virtual Annual Meeting, October 23, 2021

Current and Future Impact of the HPV Vaccine
American Urological Association Conference, September 12, 2021

HPV Vaccination to Prevent HPV-associated Cancers
Stanford Drug Discovery Symposium, April 19, 2021

Which Stone Holds up the Bridge?
American Association of Cancer Research Virtual Annual Meeting
Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research, April 9, 2021

Children Ask Leaders: Who are you eliminating cervical cancer for?
World Cancer Day, January 29, 2021

Preventing HPV-associated Cancers in Low- and Middle-income Countries (LMICs)
American Society for Radiation Oncology Virtual Annual Meeting, October 24-28, 2020

NCI and Cancer Research: Focused on the Future
Ohio State University Comprehensive Cancer Center Annual Scientific Meeting, October 13, 2020

Launch of SeroNet – Media Briefing
National Cancer Institute, October 8, 2020

COVID-19 Diagnostics Development
American Association for Cancer Research Virtual Meeting: COVID-19 and Cancer, July 21, 2020

AACR Distinguished Public Service Award Lecture
American Association for Cancer Research, Virtual Annual Meeting II, June 23, 2020

Final Thoughts and a Charge for the Future
NCI Childhood Cancer Data Initiative Symposium, July 31, 2019

Remarks from the NIH Hematology Oncology Fellowship Commencement
National Institutes of Health, June 21, 2019

Remarks from the National Cancer Institute Deputy Director
American Association for Cancer Research Annual Meeting, March 31, 2019

A Vaccine Against Cancer – 2017 Lasker-DeBakey Clinical Medical Research Award
Albert and Mary Lasker Foundation, September 2017

A Balanced Approach to Addressing Cancer
American Association for Cancer Research Annual Meeting, April 3, 2017

National Coalition for Cancer Research & One Voice Against Cancer Moonshot Blue Ribbon Panel Report
September 27, 2016

Seizing Today's Opportunities to Accelerate Cancer Research: An Update on the NCI Blue Ribbon Panel and a Dialogue with Early Career Investigators
American Association for Cancer Research Congressional Briefing, June 28, 2016

The HPV Vaccine: FDA Approval Was Just the Beginning
15th Annual Cancer Research Symposium on Prevention and Early Detection of Cancer, Koch Institute, MIT, June 10, 2016

Many Opportunities to Accelerate Progress in Cancer Research
American Association for Cancer Research Annual Meeting, April 18, 2016

HPV Vaccines: Recent Advances and the Potential for Further Progress
American Association for Cancer Research Annual Meeting, April 18, 2016

Understanding and Overcoming Cancer Disparities in the US and Abroad
Keynote Address, American Association for Cancer Research Health Disparities Conference, November 13, 2015

Director's Message: NCI Annual Plan & Budget Proposal for Fiscal Year 2017
September, 2015

Drastically Reducing HPV-Associated Cancers through Etiologically Based Primary and Secondary Prevention
American Association for Cancer Research Annual Meeting, April 20, 2015

Oncogenic Viruses: Past, Present, and Future.
National Academy of Sciences Annual Meeting: A Symposium on Cancer: From Basic Science to New Treatments, Prevention, and Back. April 28, 2014

Human Papillomavirus: Preventing Cancer
NIH/FAES 2014 Demystifying Medicine Series, March 25, 2014

NCI Childhood Cancer Data Initiative Symposium: Final Thoughts

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Selected Presentations by NCI Acting Director Dr. Douglas Lowy was originally published by the National Cancer Institute.”